.css-1xsl8rf{width:100%;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;position:relative;overflow:hidden;background:var(--alert-bg);-webkit-padding-start:var(--chakra-space-4);padding-inline-start:var(--chakra-space-4);-webkit-padding-end:var(--chakra-space-4);padding-inline-end:var(--chakra-space-4);padding-top:var(--chakra-space-1);padding-bottom:var(--chakra-space-1);--alert-fg:var(--chakra-colors-orange-600);--alert-bg:var(--chakra-colors-orange-100);font-weight:var(--chakra-fontWeights-semibold);padding-left:var(--chakra-space-4);}.chakra-ui-dark .css-1xsl8rf:not([data-theme]),[data-theme=dark] .css-1xsl8rf:not([data-theme]),.css-1xsl8rf[data-theme=dark]{--alert-fg:var(--chakra-colors-orange-200);--alert-bg:rgba(251, 211, 141, 0.16);}@media screen and (min-width: 48em){.css-1xsl8rf{padding-left:var(--chakra-space-8);}}Please enable Javascript to use all features and improve your user experience.

Nina Fransen

Utrecht, NL

Utrecht University Medical Centre

Chair

13/09/2023
16:45 – 18:15
Scientific session - Neuroimmunology
Demyelinating Diseases
Bernhard von Langenbeck (1st floor)
small auditorium, 90 seats
Neuroimmunology

Speaker

14/09/2023
ePoster
PS5-NI-A243
Rasmussen encephalitis in a case with mild malformation of cortical development with oligodendroglial hyperplasia and epilepsy (MOGHE) with SLC35A2 brain mosaicism
14/09/2023
13:03 – 13:09 4 Min. 2 Min.
ePoster Talk
PS5-NI-A243
Rasmussen encephalitis in a case with mild malformation of cortical development with oligodendroglial hyperplasia and epilepsy (MOGHE) with SLC35A2 brain mosaicism

Further involvements

14/09/2023
ePoster
PS5-NI-A243
Rasmussen encephalitis in a case with mild malformation of cortical development with oligodendroglial hyperplasia and epilepsy (MOGHE) with SLC35A2 brain mosaicism
14/09/2023
13:03 – 13:09 4 Min. 2 Min.
ePoster Talk
PS5-NI-A243
Rasmussen encephalitis in a case with mild malformation of cortical development with oligodendroglial hyperplasia and epilepsy (MOGHE) with SLC35A2 brain mosaicism